4//SEC Filing
Turtle Cameron 4
Accession 0001636282-25-000008
CIK 0001636282other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:35 PM ET
Size
359.1 KB
Accession
0001636282-25-000008
Insider Transaction Report
Form 4
Turtle Cameron
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-15+370,000→ 370,000 totalExercise: $21.66Exp: 2035-01-15→ Common Stock (370,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 370,000 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001758363
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:35 PM ET
- Size
- 359.1 KB